Cargando…

Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()

Loss of function mutations of the protein MICU1, a regulator of mitochondrial Ca(2 +) uptake, cause a neuronal and muscular disorder characterised by impaired cognition, muscle weakness and an extrapyramidal motor disorder. We have shown previously that MICU1 mutations cause increased resting mitoch...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhosale, Gauri, Sharpe, Jenny A., Koh, Amanda, Kouli, Antonina, Szabadkai, Gyorgy, Duchen, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Pub. Co 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424885/
https://www.ncbi.nlm.nih.gov/pubmed/28132899
http://dx.doi.org/10.1016/j.bbamcr.2017.01.015
_version_ 1783235208201371648
author Bhosale, Gauri
Sharpe, Jenny A.
Koh, Amanda
Kouli, Antonina
Szabadkai, Gyorgy
Duchen, Michael R.
author_facet Bhosale, Gauri
Sharpe, Jenny A.
Koh, Amanda
Kouli, Antonina
Szabadkai, Gyorgy
Duchen, Michael R.
author_sort Bhosale, Gauri
collection PubMed
description Loss of function mutations of the protein MICU1, a regulator of mitochondrial Ca(2 +) uptake, cause a neuronal and muscular disorder characterised by impaired cognition, muscle weakness and an extrapyramidal motor disorder. We have shown previously that MICU1 mutations cause increased resting mitochondrial Ca(2+) concentration ([Ca(2 +)](m)). We now explore the functional consequences of MICU1 mutations in patient derived fibroblasts in order to clarify the underlying pathophysiology of this disorder. We propose that deregulation of mitochondrial Ca(2+) uptake through loss of MICU1 raises resting [Ca(2+)](m), initiating a futile Ca(2+) cycle, whereby continuous mitochondrial Ca(2+) influx is balanced by Ca(2+) efflux through the sodium calcium exchanger (NLCX(m)). Thus, inhibition of NCLX(m) by CGP-37157 caused rapid mitochondrial Ca(2+) accumulation in patient but not control cells. We suggest that increased NCLX activity will increase sodium/proton exchange, potentially undermining oxidative phosphorylation, although this is balanced by dephosphorylation and activation of pyruvate dehydrogenase (PDH) in response to the increased [Ca(2+)](m). Consistent with this model, while ATP content in patient derived or control fibroblasts was not different, ATP increased significantly in response to CGP-37157 in the patient but not the control cells. In addition, EMRE expression levels were altered in MICU1 patient cells compared to the controls. The MICU1 mutations were associated with mitochondrial fragmentation which we show is related to altered DRP1 phosphorylation. Thus, MICU1 serves as a signal–noise discriminator in mitochondrial calcium signalling, limiting the energetic costs of mitochondrial Ca(2+) signalling which may undermine oxidative phosphorylation, especially in tissues with highly dynamic energetic demands. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech.
format Online
Article
Text
id pubmed-5424885
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier Pub. Co
record_format MEDLINE/PubMed
spelling pubmed-54248852017-06-01 Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics() Bhosale, Gauri Sharpe, Jenny A. Koh, Amanda Kouli, Antonina Szabadkai, Gyorgy Duchen, Michael R. Biochim Biophys Acta Article Loss of function mutations of the protein MICU1, a regulator of mitochondrial Ca(2 +) uptake, cause a neuronal and muscular disorder characterised by impaired cognition, muscle weakness and an extrapyramidal motor disorder. We have shown previously that MICU1 mutations cause increased resting mitochondrial Ca(2+) concentration ([Ca(2 +)](m)). We now explore the functional consequences of MICU1 mutations in patient derived fibroblasts in order to clarify the underlying pathophysiology of this disorder. We propose that deregulation of mitochondrial Ca(2+) uptake through loss of MICU1 raises resting [Ca(2+)](m), initiating a futile Ca(2+) cycle, whereby continuous mitochondrial Ca(2+) influx is balanced by Ca(2+) efflux through the sodium calcium exchanger (NLCX(m)). Thus, inhibition of NCLX(m) by CGP-37157 caused rapid mitochondrial Ca(2+) accumulation in patient but not control cells. We suggest that increased NCLX activity will increase sodium/proton exchange, potentially undermining oxidative phosphorylation, although this is balanced by dephosphorylation and activation of pyruvate dehydrogenase (PDH) in response to the increased [Ca(2+)](m). Consistent with this model, while ATP content in patient derived or control fibroblasts was not different, ATP increased significantly in response to CGP-37157 in the patient but not the control cells. In addition, EMRE expression levels were altered in MICU1 patient cells compared to the controls. The MICU1 mutations were associated with mitochondrial fragmentation which we show is related to altered DRP1 phosphorylation. Thus, MICU1 serves as a signal–noise discriminator in mitochondrial calcium signalling, limiting the energetic costs of mitochondrial Ca(2+) signalling which may undermine oxidative phosphorylation, especially in tissues with highly dynamic energetic demands. This article is part of a Special Issue entitled: ECS Meeting edited by Claus Heizmann, Joachim Krebs and Jacques Haiech. Elsevier Pub. Co 2017-06 /pmc/articles/PMC5424885/ /pubmed/28132899 http://dx.doi.org/10.1016/j.bbamcr.2017.01.015 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bhosale, Gauri
Sharpe, Jenny A.
Koh, Amanda
Kouli, Antonina
Szabadkai, Gyorgy
Duchen, Michael R.
Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()
title Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()
title_full Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()
title_fullStr Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()
title_full_unstemmed Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()
title_short Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics()
title_sort pathological consequences of micu1 mutations on mitochondrial calcium signalling and bioenergetics()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424885/
https://www.ncbi.nlm.nih.gov/pubmed/28132899
http://dx.doi.org/10.1016/j.bbamcr.2017.01.015
work_keys_str_mv AT bhosalegauri pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics
AT sharpejennya pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics
AT kohamanda pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics
AT kouliantonina pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics
AT szabadkaigyorgy pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics
AT duchenmichaelr pathologicalconsequencesofmicu1mutationsonmitochondrialcalciumsignallingandbioenergetics